valeriana 30 mg film - coated tablets
Медика АД. - Валериана - 30 mg film - coated tablets
valeriana max 200 mg film - coated tablets
Медика АД. - 200 mg film - coated tablets
tinctura valerianae kupro 200 mg/ml oral drops, solution
Купро 94" ООД" - Валериана - 200 mg/ml oral drops, solution
tinctura valerianae chemax pharma 200 mg/ml oral drops, solution
Химакс Фарма ЕООД - Валериана - 200 mg/ml oral drops, solution
imvanex
bavarian nordic a/s - модифицирана ваксиния Анкара - баварски северни (mva-bn) вируси - smallpox vaccine; monkeypox virus - Други вирусни ваксини, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 и 5. Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Хеморагична Треска Ебола - Ваксини - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
vaxchora
bavarian nordic a/s - холерный вибрион, щам и ИЗРАВНИТЕЛНИТЕ 103-hgr за да живеят - холера - Ваксини - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. Тази ваксина трябва да се използва в съответствие с официалните препоръки.
tinctura valerianae vt oral drops, solution
oral drops, solution
Анервина перорални капки, разтвор - 50 ml
Химакс Фарма" ЕООД" - Натриев бромид, амониев бромид, калий бромид, тинктура Валериане -
heplisav b
dynavax gmbh - повърхностен антиген на хепатит В - Хепатит Б - Ваксини - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.